AllisonBethanneReissMD

PubMed

• Hydroxychloroquine Effects on THP-1 Macrophage Cholesterol Handling: Cell Culture Studies Corresponding to the TARGET Cardiovascular Trial.
  Saba Ahmed, Justin Konig, Lora J Kasselman, Heather A Renna, Joshua De Leon
  Medicina. 2022-09-16
• 4 citations
  Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model.
  Lora J Kasselman, Heather A Renna, Iryna Voloshyna, Aaron Pinkhasov, Irving H Gomolin
  Journal of Traditional and Complementary Medicine. 2022-09-01
• 1 citations
  Special Issue on "Advances in Cholesterol and Lipid Metabolism".
  Allison B Reiss, Joshua De Leon
  Metabolites. 2022-08-19

Journal Articles

• Accelerated Atherosclerosis in the Setting of Chronic Kidney Disease  
  Reiss, A.B., Glass, A.D., Renna, H.A., Grossfeld, D.J., Glass, D.S., Kasselman, L.J., De Leon, J, Archives of Nephrology., 1/1/2018
• PCSK9 in cholesterol metabolism: from bench to bedside  
  Reiss, A.B., Shah, N., Muhieddine, D., Zhen, J., Yudkevich, J., Kasselman, L.J., DeLeon, J., Clin Sci (Lond), 1/1/2018
• The Gut Microbiome and Elevated Cardiovascular Risk in Obesity and Autoimmunity  
  Kasselman, L.J., Vernice, N.A., De Leon, J., Reiss, A.B., Atherosclerosis, 1/1/2018
• Amyloid Toxicity in Alzheimer�s Disease  
  Reiss, A.B., Arain, H.A., Stecker, M.M., Siegart, N.M., Kasselman, L.J., Rev. Neurosci., 1/1/2018
• Exosomes in Cholesterol Metabolism and Atherosclerosis Cardiovasc Hematol Disord Drug Targets  
  Reiss, A.B., Vernice, N.A., Siegart, N.M., De Leon, J., Kasselman, L.J., Cardiovasc Hematol Disord Drug Targets., 1/1/2017
• Amyloidosis and the Kidney  
  Reiss, A.B., Siegart, N.M., Renna, H.A., De Leon, J., Kasselman, L.J., Miyawaki, N., The Scientific Pages of Nephrology, 1/1/2017
• Interleukin-6 in atherosclerosis: atherogenic or atheroprotective?  
  Reiss, A.B., Siegart N.M., DeLeon, J., Clinical Lipidology., 1/1/2017
• COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages  
  Voloshyna, I., Kasselman, L.J., Carsons, S.E., Littlefield, M.J., Gomolin, I.H., De Leon, J., Reiss, A.B., J Investig Med., 1/1/2017
• Intensive versus Standard Therapy for Hypertension: The Clinical Trials  
  Shah, N., Siegart, N.M., De Leon, J., Reiss, A.B., J Hypertens Manag, 1/1/2016
• Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux  
  Voloshyna, I., Teboul, I., Littlefield, M.J., Siegart, N.M., Turi, G.K., Fazzari, M.J., Carsons, S.E., DeLeon, J., Reiss, A.B., Exp Biol Med (Maywood)., 1/1/2016
• The Adenosine A2A Receptor Agonist UK-432,097 Stimulates Expression of Anti-Atherogenic Reverse Cholesterol Transport Proteins  
  Reiss, A.B., Moosa, S., Siegart, N.M., Kasselman, L.J., Rob, S., Carsons, S.E., DeLeon, J., Voloshyna, I., JCvD, 1/1/2016
• Effect of inhibition of IL-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophages  
  Voloshyna, I., Mounessa, J., Carsons, S.E., Reiss, A.B., Clin Exp Dermatol., 1/1/2016
• Plasma IL-33 in atopic patients correlates with pro-inflammatory cytokines and changes cholesterol transport protein expression: a surprising neutral overall impact on...  
  Voloshyna, I., Mucci, T., Sher, J., Fonacier, L.S., Littlefield, M.J., Carsons, S., Reiss, A.B., Clin Exp Allergy., 1/1/2015
• Cholesterol Metabolism in Chronic Kidney Disease  
  Reiss, A.B., Voloshyna, I., Deleon, J., Miyawaki, N., Mattana, J., Am J Kidney Dis., 1/1/2015
• Polarization of Human THP-1 Macrophages: Link between Adenosine Receptors, Inflammation and Lipid Accumulation  
  Littlefield, M.J., Teboul, I., Voloshyna, I., Reiss, A.B., J Immunol Immunother, 1/1/2014
• Advanced Glycation End Products Promote Pro-atherogenic Changes in Cholesterol Transport: A Possible Mechanism for Cardiovascular Risk  
  Voloshyna, I., Gamez-Godoy, J., Littlefield, M., De Leon, J., Castro-Magana, M., Reiss, A.B., Intern Med., 1/1/2014
• Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-alpha: A Possible Mechanism for Modulation of Atherogenesis  
  Voloshyna, I., Seshadri, S., Anwar, K., Littlefield, M.J., Belilos, E., Carsons, S.E., Reiss, A.B., BioMed Research International, 1/1/2014
•  
  Voloshyna, I., Littlefield, M.J., and Reiss, A.B., Trends in Cardiovascular Medicine, 1/1/2014
• Plasma from Rheumatoid Arthritis Patients Promotes Pro-atherogenic Cholesterol Transport Gene Expression in THP-1 Human Macrophages  
  Voloshyna, I., Modayil, S., Littlefield, M.J., Belilos, E., Belostocki, K.B., Bonetti, L., Rosenblum, G.C., Carsons, S.E., Reiss, A.B., Exp. Biol. Med. (Maywood)., 1/1/2013
• Adenosine A(2A) receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells  
  Voloshyna, I., Carsons, S., Littlefield, M.J., Rieger, J.M., Figler, R., and Reiss, A.B., Biochim. Biophys. Acta., 1/1/2013
•  
  Voloshyna, I., Hai, O., Littlefield, M.J., Carsons, S.E., and Reiss, A.B., Eur. J. Pharmacol, 1/1/2013
• Resveratrol in cholesterol metabolism and atherosclerosis  
  Voloshyna, I., Hussaini, S.M., and Reiss, A.B., J. Med. Food., 1/1/2012
• Regulation of cerebral cholesterol metabolism in Alzheimer�s disease  
  Reiss, A.B., Voloshyna, I., J. Investig. Med., 1/1/2012
• Regulation of foam cells by adenosine  
  Reiss, A.B., Cronstein, B.N., Arterioscler Thromb Vasc Biol., 1/1/2012
• The ABC transporters in lipid flux and atherosclerosis  
  Voloshyna I, Reiss, A.B., Prog. Lipid Res, 1/1/2011
• Join now to see all

Books/Book Chapters

• Cytochrome P450 Enzymes: Biochemistry, Pharmacology and Health Implications. 
  Chapter: Cytochrome P450 Enzymes in Atherosclerosis 
  Page 87.0 - 107.0Voloshyna, I., and Reiss, A.B.Editors: Jian Wu.Nova Science Publishers2014
• Adenosine Receptors: Therapeutic Aspects for Inflammatory and Immune Diseases. 
  Chapter: Adenosine in Atherosclerosis 
  Page 313.0 - 325.0Reiss, A.B.Editors: Hasko, G., Cronstein, B.N., and Csaba S.CRC Press.2007
• Proteins Involved in the Pathogenesis of Atherosclerosis 
  Chapter: Scavenger Receptors that Mediate Uptake of Oxidized Low-Density Lipoprotein and Foam Cell Formation 
  Page 1.0 - 12.0Reiss, A.B., and Glass, A.D. CD36 and ScR-AEditors: Reiss, A.B., Carsons, S., and Cronstein, B.N..Research Signpost2006
• Proteins Involved in the Pathogenesis of Atherosclerosis. 
  Chapter: Matrix Proteases in Atherosclerosis 
  Page 139.0 - 149.0Chan, E.S.L., Fernandez, P., Zhang, H., and Reiss, A.B.Editors: Reiss, A.B., Carsons, S., and Cronstein, B.N..Research Signpost.2006
• Lupus: Molecular and Cellular Pathogenesis. 
  Chapter: The vascular endothelium, a new actor in the pathogenesis of vascular injury in sysyemic lupuserythematosis. 
  Cronstein, B.N., Reiss, A.B., and Malhotra, S.Editors: Kammer, G.M..1998
• Join now to see all

Abstracts/Posters

• Exploring Abnormalities in Lung MicroRNAs in Idiopathc Pulmonary Fibrosis using Exhaled Breath Condensate
  Pletukhina N, Kasselman LJ, Salzman SH, Renna HA, Reiss AB, Agarwala P., J Investig Med., 1/1/2018
• The Effect of B-hydroxybutyrate on Human Microglia: Implications for the Ketogenic Diet in Neurodegenerative Disorders.
  Kasselman LJ, Chevalier C, Zhen J, Grossfeld D, Pinkhasov A, Gomolin I, Reiss AB, J Investig Med, 1/1/2018
• Microglia in a Hyperglycemic Environment Promote Alzheimer's Disease-Like Pathology through Cholingergic Synaptic Dysfunction and Increased Amyloid beta Production.
  Arain HA, Renna HA, Kasselman LJ, Pinkhasov A, Gomolin I, Jacobson AM, De Leon J, Fazzari MJ, Reiss AB., J Investig Med, 1/1/2018
• Atherosclerosis in Autoimmune Rheumatic Diseases: Comparison of Plasma Effects on Macrophage Cholesterol Balance in vitro, and Correlation to Traditional Cardiovascula...
  Maidhof A, Kasselman LJ, Carsons S, Belilos E, Belostocki K, Rosenblum G, Bonetti L, Fazzari M, DeLeon J, Reiss AB, J Investig Med, 1/1/2018
• Evaluation of Biologic Therapy versus Triple DMARD Therapy in RA Patients Unresponsive To Methotrexate.
  Vernice NA, Reiss AB, Renna HA, De Leon J, Carsons S, Kasselman LJ, J Investig Med., 1/1/2018
• Pro-atherogenic properties of plasma from patients with type 1 diabetes mellitus: effects on macrophage lipid handling.
  De Leon JR, Mejia Corletto J, Accacha S, Voloshyna I, Siegart S, Kasselman L, Castro Magana M, Reiss A., J Am Coll Cardiol., 1/1/2017
• Statins Were Not Effective in Promoting Cholesterol Balance In Human Macrophages Treated with Systemic Lupus Erythematosus Plasma: A Gene Expression Analysis and Impli...
  Arain HA, Petri M, Kasselman LJ, Siegart NM, Renna HA, Carsons SE, De Leon J, Reiss AB., J Invest Med., 1/1/2017
• Peripheral Blood Mononuclear Cells of CIRT Patients Maintain Their Adenosine A2A Receptors in the Presence of Low Dose Methotrexate.
  Teboul I, Reiss AB, Siegart NM, Kasselman LJ, Carsons SE, De Leon J, J Invest Med., 1/1/2017
• Adipocyte-derived Exosomes from Obese Subjects have Atherogenic Effects on Cholesterol Efflux in THP-1 Human Macrophages.
  Siegart NM, Reiss AB, De Leon J, Voloshyna I, Barlev A, Salama M, Ferrante S, Nadler E, Freishtat RJ., J Invest Med., 1/1/2017
• Novel Insight into Impaired Cholesterol Transport in Chronic Kidney Disease: Demonstration of Reversibility with Vitamin D and ACE-Inhibitor
  Daccueil F, Siegart NM, Reiss AB, Renna HA, Arain HA, Kasselman LJ, Mattana J, De Leon J, Miyawaki N., J Invest Med, 1/1/2017
• Blockade of the Receptor for Advanced Glycation End Products is Not Sufficient to Prevent Atherogenic Disruption of Lipid Metabolism by Plasma from Type 1 Diabetes Pat...
  Accacha S, Reiss AB, Mejia-Corletto J, Siegart NM, Renna HA, Castro-Magana M, De Leon J, Kasselman LJ., J Invest Med., 1/1/2017
• Abnormalities in Cholesterol Flux Pathway Induced by Plasma from Patients with Chronic Kidney Disease.
  Daccueil F, Reiss AB, Siegart NM, Mattana J, Voloshyna I, Kasselman L, De Leon J, Miyawaki N., J Am Soc Nephrol., 1/1/2016
• BMI-dependent effects of adipose tissue exosomes on human macrophage cholesterol transport gene expression.
  Reiss, A.B., DeLeon, J., Voloshyna, I., Ferrante, S., Siegart, N., Barlev, A., Littlefield, M., Salama, M., Kasselman, L.J., Freishtat, R., J Am Coll Cardiol, 1/1/2016
• Comparative Effect of Selective and Non-Selective Cox-2 Inhibitors on Lipid Accumulation in Human Macrophages.
  Kasselman, L.J., Voloshyna, I., Littlefield, M.J., Siegart, N., Carsons, S.E., Gomolin, I., De Leon, J., Reiss, A.B., J Invest Med, 1/1/2016
• Correcting Atherogenic Effects of Lupus Plasma on Macrophages with Resveratrol and Mycophenolate.
  Siegart, N.M., Voloshyna, I., De Leon, J., Carsons, S.E., Teboul, I., Kasselman, L.J., Mattana, J., Reiss, A.B., J Invest Med, 1/1/2016
• The Adenosine A2A Receptor Agonist UK-432,097 Stimulates Anti-Atherogenic Reverse Cholesterol Transport Proteins in THP-1 Human Macrophages.
  Moosa, S., Voloshyna, I., Siegart, N.M., De Leon, J., Carsons, S.E., Kasselman, L.J., Littlefield, M.J., Reiss, A.B., J Invest Med., 1/1/2016
• Cholesterol Flux Pathway Abnormalities Induced by Plasma from Patients with Chronic Kidney Disease
  Miyawaki, N., Daccueil, F., Siegart, N.M., Mattana, J., Voloshyna, I., Kasselman, L.J., De Leon, J., Reiss, A.B., J Invest Med., 1/1/2016
• Inhibition of the Receptor for Advanced Glycation End Products Restores Cholesterol Efflux in THP-1 Human Macrophages Exposed to Plasma from Type 1 Diabetes Mellitus P...
  Mejia Corletto, J., Accacha, S., Voloshyna, I., Siegart, N., Kasselman, L., Castro Magana, M., De Leon, J., Reiss, A.B., J Invest Med, 1/1/2016
• Novel Mechanism for Cardiovascular Protective Effect of Vitamin D and ACE inhibitors in Chronic Kidney Disease: Correction of Impaired Cholesterol Efflux Induced by Pl...
  Miyawaki N, Siegart NM, Renna HA, Arain HA, Daccueil F, Mattana J, De Leon J, Reiss AB., J Am Soc Nephrol, 1/1/2016
• Atherogenic Impact of Adipocyte Exosomes from Obese Adolescents on Human Macrophage Cholesterol Handling: A Potential Mechanism Linking Excess Weight and Cardiovascula...
  Reiss AB, De Leon J, Siegart NM, Voloshyna I, Ferrante S, Barlev A, Nadler EP, Salama M, Kasselman LJ, Freishtat RJ., Obesity Week, 1/1/2016
• Comparative Effect of Ustekinumab and Adalimumab on Expression of Leptin and Leptin Receptor in THP-1 Human Macrophages.
  Mounessa, J.S., Reiss, A.B., Carsons, S.E., Voloshyna, I., J Invest Med., 1/1/2015
• Obesity and Atherosclerosis: Exosome Effect on Cholesterol Efflux in THP-1 Human Macrophages.
  Barlev, A., Voloshyna, I., Ferrante, S.C., Salama, M., Littlefield, M.J., Reiss, A.B., Freishtat, R.J., J Invest Med., 1/1/2015
• Role of Adenosine A2A and A3 Receptors in Macrophage Polarization: Link between Inflammation and Lipid Accumulation.
  Teboul, I., Voloshyna, I., Littlefield, M., Mattana, J., De Leon, J., Reiss, A.B., J Invest Med., 1/1/2015
• Do Classically Activated M1 Macrophages Display Pro-Atherogenic Changes in Cholesterol Transport Proteins?
  Wallace, M.B., Voloshyna, I., Teboul, I., Littlefield, M.J., De Leon, J., Reiss, A.B., J Invest Med, 1/1/2015
• Immunosuppressive Drugs Mycophenolate Mofetil and Cyclosporin A: Disparate Effects on Atherogenic Lipid Accumulation in THP-1 Human Macrophages
  Salama, M., Voloshyna, I., Littlefield, M.J., Teboul, I., De Leon, J., Carsons, S.E., Mattana, J., Reiss, A.B., J Invest Med, 1/1/2015
• Join now to see all

Lectures

• Building Your Career: Getting Published in High Quality Biomedical Journals 
  1/1/2010
• Neurodegenerative Diseases: Pathogenesis and Treatment from Bench to Bedside 
  Washington Convention Center, Washington, DC - 1/11/2011
• Inhibiting Cyclooxygenase with Coxibs and NSAIDs: Efficacy vs. Cardiovascular Risk 
  San Diego Convention Center, San Diego, CA - 1/8./2008
• Immune and Inflammatory Influence on Cholesterol Metabolism in Atherogenic Disorders 
  Winthrop University Hospital - 1/7./2008
• Principles of Grant Writing 
  1/25/2009
• Grant Writing for Projects Involving Human Subjects 
  1/15/2009
• Atheroprotective Effects of Methotrexate on reverse Cholesterol Transport Proteins 
  Glen Cove Mansion - 1/14/2009
• Increased Cardiovascular Risk with Pain-relieving Coxib Medications: Disruption of Cholesterol Metabolism 
  Winthrop Clinical Trials Center. - 1/21/2009
• Impact of Autoimmune Rheumatic Diseases and Anti-inflammatory Agents on Cholesterol Metabolic Signature in Humans 
  1/7./2010
• Impact of Anti-inflammatory Agents on Cholesterol Metabolic Signature in Humans 
  Winthrop Clinical Trials Center. - 1/13/2010
• Lipid Metabolism in the Pathogenesis of Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases 
  Winthrop University Hospital - 1/21/2010
• Increased Risk of Heart Attack with Pain-relieving Medications: Disruption of Cholesterol Metabolism. 
  1/22/2007
• Cardiovascular Risk in Autoimmune Rheumatic Disorders 
  Omni Shoreham Hotel, Washington, DC - 1/27/2011
• Basic Research 
  1/14/2011
• Updates in Current NSAIDS trial 
  Winthrop Clinical Trials Center - 1/7./2011
• Adenosine A2A Receptor Ligation Corrects Disrupted Lipid Metabolism: A Potential Therapeutic Strategy for Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases 
  Center for Cardiovascular Disease Prevention Brigham and Women's Hospital, Boston - 1/1./2012
• Atheroprotective Effects of Adalimumab and Resveratrol in THP-1 Human Macrophages: Changes in Expression of Proteins Involved in Lipid Efflux 
  1/29/2014
• Atheroprotective Effects of Resveratrol in Models of Systemic Lupus Erythematosus 
  1/16/2015
• Regulation of Cerebral Cholesterol Metabolism in Alzheimer�s Disease 
  Alzheimer�s Disease Resource Center - 1/9./2015
• Progress in Alzheimer�s Disease: Developments in Prediction and Treatment. 
  ADRC 4th Annual Physicians� Outreach Dinner - 1/6./2016
• Breaking Out of the Box: New Ways to Understand and Treat Alzheimer's Disease 
  Levittown Library, Levittown NY. - 1/16/2016
• Alzheimer's Disease and Diabetes: New Insights and Approaches 
  Farmingdale Library, Farmingdale NY - 1/17/2017
• Serum from SLE Patients Compromises Cholesterol Homeostasis in Cultured Human Aortic Endothelial Cells (HAEC) by Decreasing Cholesterol 27-Hydroxylase Expression 
  1/12/2003
• Immune Complexes in Atherosclerosis. 
  1/17/1997
• Occupancy of C1q Receptors on Endothelial Cells by Immune Complexes Downregulates mRNA for Sterol 27-Hydroxylase, the Major Mediator of Extra-hepatic Cholesterol Metab... 
  San Diego - 1/8./1998
• Join now to see all